Identification of differentially expressed genes after acute exposure to bulaquine (CDRI 80/53) in mice liver

Basic and Clinical Pharmacology and Toxicology

Volumn 103, Issue 6, 2008, Pages 522-529

  Noel, Sanjeev ^a   Sharma, Sharad ^a   Shankar, Rishi ^b   Rath, Srikanta Kumar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

8 [4 (3 ACETYL 4,5 DIHYDRO 2 FURYLAMINO) 1 METHYLBUTYLAMINO] 6 METHOXYQUINOLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; DRUG RESPONSE; DRUG SAFETY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; TOXICITY TESTING;

ALANINE TRANSAMINASE; ANIMALS; ANTIMALARIALS; ASPARTATE AMINOTRANSFERASES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; LIVER; MALE; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; PRIMAQUINE; RNA, MESSENGER;

MUS; PLASMODIUM OVALE; PLASMODIUM VIVAX;

EID: 56049119639     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00279.x     Document Type: Article

References (20)

1. Gogtay NJ, Kamtekar KD, Dalvi SS, Mehta SS, Chogle AR, Aigal U et al. A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria. BMC Infect Dis 2006 6 : 16.
2. Clyde DF. Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug. Bull World Health Organ 1981 59 : 391 5.
3. Bruce-Chwatt LJ, Black RH, Canfield CJ, Clyde DF, Peters W, Wernsdorfer WH. Chemotherapy of Malaria, 2nd edn. Monogram Series No. 27. World Health Organization, Geneva, Switzerland, 1981 30 80.
4. Dutta GP, Puri SK, Bhaduri AP, Seth M. Radical curative activity of a new 8-aminoquinoline derivative (CDRI 80/53) against Plasmodium cynomolgi B in monkeys. Am J Trop Med Hyg 1989 41 : 635 7.
5. Bhat BK, Seth M, Bhaduri AP. Recent developments in 8-aminoquinoline antimalarials. Prog Drug Res 1984 28 : 197 231.
6. Puri SK, Srivastava R, Pandey VC, Sethi N, Dutta GP. Methemoglobin toxicity and hematological studies on malaria anti-relapse compound CDRI 80/53 in dogs. Am J Trop Med Hyg 1989 41 : 638 42.
7. Dutta GP, Puri SK. Standardization of Plasmodium cynomolgi B rhesus monkey model for radical curative test and primaquine sensitivity of the relapse stages of the parasite from different cyclic passages. Int J Parasitol 1988 12 : 109 15.
8. Mehrotra N, Lal J, Puri SK, Madhusudanan KP, Gupta RC. In vitro and in vivo pharmacokinetic studies of bulaquine (analogue of primaquine), a novel antirelapse antimalarial, in rat, rabbit and monkey-highlighting species similarities and differences. Biopharm Drug Dispos 2007 28 : 209 27.
9. Minami K, Saito T, Narahara M, Tomita H, Kato H, Sugiyama H et al. Relationship between hepatic gene expression profiles and hepatotoxicity in five typical hepatotoxicant-administered rats. Toxicol Sci 2005 87 : 296 305.
10. Noel S, Sharma S, Shanker R, Rath SK. Primaquine-induced differential gene expression analysis in healthy mice liver using DNA microarrays. Toxicology 2007 239 : 96 107.
11. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003 34 : 374 8.
12. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 2002 31 : 19 20.
13. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, Conklin BR. MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 2003 4 : R7.1 R7.12.
14. Chung H, Hong DP, Jung JY, Kim HJ, Jang KS, Sheen YY et al. Comprehensive analysis of differential gene expression profiles on carbon tetrachloride-induced rat liver injury and regeneration. Toxicol Appl Pharmacol 2005 206 : 27 42.
15. Waring JF, Ciurlionis R, Jolly RA, Heindel M, Ulrich RG. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol Lett 2001 120 : 359 68.
16. Churchill GA. Fundamentals of experimental design for cDNA microarrays. Nat Genet 2002 32 (suppl. 490 5.
17. Peng X, Wood CL, Blalock EM, Chen KC, Landfield PW, Stromberg AJ. Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinformatics 2003 4 : 26.
18. Pandey VC, Puri SK, Sahni SK, Srivastava P, Dutta GP. Effect of anti-relapse antimalarial compound CDRI 80/53 and primaquine on hepatic mixed function oxidase system of rhesus monkey. Pharm Res 1990 22 : 701 7.
19. Dean Goldring JP, Nemaorani S. Antimalarial drugs modulate the expression of monocyte receptors. Int J Immunopathol pharmacol 1999 21 : 599 607.
20. Hara Y, Kizaki K. Antimalarial drugs inhibit the acetylcholine receptor-operated potassium current in atrial myocytes. Heart Lung Circ 2002 11 : 112 6.